🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Aml I. Mekkawy

Assiut University

ORCID: 0000-0003-1372-1192

Also affiliated with Sohag University

Pharmacology, Toxicology and PharmaceuticsMaterials ScienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Injectable long-acting ivacaftor-loaded poly (lactide-co-glycolide) microparticle formulations for the treatment of cystic fibrosis: In vitro characterization and in vivo pharmacokinetics in mice”.

Injectable long-acting ivacaftor-loaded poly (lactide-co-glycolide) microparticle formulations for the treatment of cystic fibrosis: In vitro characterization and in vivo pharmacokinetics in mice

International Journal of Pharmaceutics(2023)10.1016/j.ijpharm.2023.123693
N/A
0.360DataRank · unranked
10 citations

Aml I. Mekkawy, Youssef W. Naguib, Aaron D. Silva Trenkle, Dylan Gao, Jeong‐Ah Kim +8 more

An Injectable Microparticle Formulation Provides Long-Term Inhibition of Hypothalamic ERK1/2 Activity and Sympathetic Excitation in Rats with Heart Failure

Molecular Pharmaceutics(2020)10.1021/acs.molpharmaceut.0c00501
N/A
0DataRank · unranked
6 citations

Yang Yu, Shun‐Guang Wei, Angie S. Morris, Brittany E. Givens, Aml I. Mekkawy +4 more

The MEK 1/2 inhibitor PD98059 exhibits synergistic anti-endometrial cancer activity with paclitaxel in vitro and enhanced tissue distribution in vivo when formulated into PAMAM-coated PLGA-PEG nanoparticles

Drug Delivery and Translational Research(2021)10.1007/s13346-021-01065-7
N/A
0DataRank · unranked
18 citations

Aml I. Mekkawy, Juliana C. Quarterman, Youssef W. Naguib, Kareem Ebeid, Sean M. Geary +2 more

Paclitaxel anticancer activity is enhanced by the MEK 1/2 inhibitor PD98059 in vitro and by PD98059-loaded nanoparticles in BRAFV600E melanoma-bearing mice

International Journal of Pharmaceutics(2021)10.1016/j.ijpharm.2021.120876
N/A
0DataRank · unranked
25 citations

Youssef W. Naguib, Suhaila O. Alhaj‐Suliman, Emad I. Wafa, Kareem Ebeid, Timothy M. Acri +2 more